Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.
about
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAHuman T cell responses to Japanese encephalitis virus in health and diseaseStatus of hepatitis C virus vaccination: Recent updateImmune and non-immune responses to hepatitis C virus infectionDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsMeasuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesHepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?State-of-the-art human gene therapy: part I. Gene delivery technologiesImmune responses to HCV and other hepatitis virusesT cell responses in hepatitis C virus infection: historical overview and goals for future researchA global approach to HIV-1 vaccine developmentVaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in MiceSupplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini ReviewState of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationHepatitis C.Engineering New Approaches to Cancer VaccinesIL-33 induces nuocytes and modulates liver injury in viral hepatitis.The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine designImmunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virusAdvanced molecular surveillance of hepatitis C virusGlobal geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwideAssessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.Human parvovirus 4 'PARV4' remains elusive despite a decade of studyLiver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.Adenoviral vectors as novel vaccines for influenza.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designFusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Protection of non-human primates against rabies with an adenovirus recombinant vaccine.CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.Protective immunity against hepatitis C: many shades of gray.Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.
P2860
Q24289279-AEAABD05-12AD-44FA-B718-64750575EB91Q24289630-3442E97E-2219-4561-844D-2829206C4A26Q26774612-11A0A2EC-227F-4432-9DE1-99EABA2EFEF2Q26782040-467EEED0-F509-4CDF-B65A-4DB82A5A05C9Q26782083-8EEA2F25-A1B2-4098-BA2C-6103BE94AF5BQ26783884-594B7941-F980-4B03-ACDC-8CAE93C10F1AQ26799141-F1504939-E3F4-4A0A-B22C-246B077E44CCQ26825575-DAE70F82-1F46-452F-A908-9CE60C3440A2Q26866955-39F4E94E-12D4-4707-9FB5-585AB44821BFQ27003510-535DF53D-BEF7-4E49-AFD4-020659D170D7Q27024614-7C67C567-C4BA-4349-8389-FD7E720C8308Q27303766-DE9767EC-E905-492E-AC75-6E7936AF3067Q28068362-E8AE7BDA-8521-4A2D-BBBD-D97AA7E13F82Q28079102-1C26F20D-8090-4C24-B02B-092C94F31BCBQ28084654-CD555A1B-A95A-4FE3-8B50-2E6D84512A74Q28085563-A710BF5A-8887-470C-9FF8-BD6887632112Q28588039-09FFC46D-470A-4988-8AC9-51AE7485165FQ28602408-52B9D3D9-ECA5-4CDD-BECC-B2187B38AEE8Q28604286-33FA6773-52D2-4953-AB75-CC138D487C0FQ28650908-48114E11-BE0E-41FC-931E-CFEAD380966BQ28706340-7F5BB7BD-9950-4036-91DA-11CFEE9EBCA5Q30208996-59D02F0D-323B-44A0-915E-4FE9FD3AD309Q30223906-A4967A83-03A4-416E-8861-752921917DABQ30238496-53D25E0C-353E-4C6F-8AE4-A8959B55D83FQ30300575-A5873FCC-66D9-4757-A5CA-9C43BD2B496DQ30370445-D3BCA6BC-6407-4E1B-ACD3-17C8AB771C82Q30374314-255BDE1B-9957-4EA1-B0F8-713F0F34EBABQ33586992-0F209047-660F-4771-A9F1-1565C7C7EC6BQ33601808-13119EE6-D449-4DB0-8320-45850559D9E4Q33602744-310332A8-047C-44BE-AA48-87FF2508A6EAQ33630150-F7160981-C9F9-4E42-B3ED-7444AF30F76FQ33684288-D403BD8B-91DC-4DDC-8233-8FE8EF4B0713Q33718778-2CCAF176-1AB4-4C67-82A1-E464FE188EF8Q33724960-7DC30F27-6AC7-4CCB-81DF-4C06E7CA25FCQ33743457-B0B4BEA5-C997-4101-B09A-88884C0BF7E2Q33759224-5DBFCE9B-682B-477A-A196-2AD38E72D9DCQ33826033-AC7FB812-79F5-40BC-894C-74DD924C48FFQ33868760-E0694840-A12B-4593-91FC-A7AE02E95D2EQ33890011-6E764E25-CA7E-4AB9-9652-DF5D238C22CCQ34028154-19069996-0E45-45EE-9FDF-508B5E09B11A
P2860
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@en
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@nl
type
label
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@en
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@nl
prefLabel
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@en
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@nl
P2093
P2860
P50
P1476
Novel adenovirus-based vaccine ...... cell responses to HCV in man.
@en
P2093
Abby Harrison
Adrian Hill
Alfredo Nicosia
Anthony Brown
Antonella Folgori
Ayako Kurioka
Chris Willberg
Cinzia Traboni
David Adams
Eleanor Barnes
P2860
P304
P356
10.1126/SCITRANSLMED.3003155
P407
P577
2012-01-01T00:00:00Z